Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 120   

Articles published

GSK 1,633.36 -19.64 (-1.19%)
price chart
GlaxoSmithKline plc (ADR) (NYSE:GSK) Survive From New Respiratory Molecule ...
GlaxoSmithKline's plc (ADR) (NYSE:GSK) respiratory franchise is going through a tough time due to fierce competition after the patent expiration of the company's blockbuster drugs and with the induction of generics in the therapeutic market.
JP Morgan maintained GlaxoSmithKline PLC (LON:GSK) as 'Neutral' With 1900 PT
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related ...
Zacks Rating on GlaxoSmithKline PLC (GSK)  TheFounders Daily
Broker Buy/Sell/Hold Updates For GlaxoSmithKline PLC (NYSE:GSK)  Fiscal Standard
Analysts Ranking Activities: Medtronic plc (NYSE:MDT) , GlaxoSmithKline PLC ...
On 8/24/2016, shares of Medtronic plc (NYSE:MDT) fell -1.31% in trading session and finally closed at $86.65. The company most recent volume stood at 5.29 million shares as compared to average volume of 4.7 million shares.
Zika Threat: GlaxoSmithKline plc (GSK), Inovio Pharmaceuticals Inc (INO ...
The threat of Zika virus has opened a new window for the pharmaceutical companies to enter into a lucrative market of vaccine production.
Stock Earnings Estimates in Limelight: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR)(NYSE:GSK) soared 0.25% or +0.11 points during previous trade after opening at the price of $44.32, a total of 3.35M shares exchanged hands compared with its average trading volume of 4.00M shares.
GlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit ...  Market Exclusive
GlaxoSmithKline upbeat despite currency hit  Proactive Investors UK
GlaxoSmithKline plc (LON:GSK) Receives Average Rating of "Hold" from Brokerages
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) has earned an average rating of “Hold” from the twenty-eight research firms that are presently covering the stock.
Shore Capital Reiterates Hold Rating for GlaxoSmithKline PLC (GSK)
GlaxoSmithKline PLC logo GlaxoSmithKline PLC (NYSE:GSK)'s stock had its “hold” rating reissued by stock analysts at Shore Capital in a research note issued to investors on Thursday.
Buzzing Stock: GlaxoSmithKline PLC (NYSE:GSK)  Equities Focus
GlaxoSmithKline plc (NYSE:GSK) – Top Stock from Healthcare Sector  The Daily Leicester
GlaxoSmithKline PLC (LON:GSK) Issued With 'Neutral' Rating At JP Morgan Cazenove
On Friday JP Morgan Cazenove retained its target for shares of GlaxoSmithKline PLC as 'Neutral' recommending a target price of 1900 for investors; potentially meaning there is an increase of 12.29% from GlaxoSmithKline PLC's share price of 1692.
Argus Boosts GlaxoSmithKline PLC (GSK) Price Target to $50.00  Community Financial News
Lockheed Martin Corporation (NYSE:LMT) & GlaxoSmithKline plc (NYSE:GSK) Stocks ...
On Tuesday, Shares of Lockheed Martin Corporation (NYSE:LMT) lost -3.19% to $256.77. The share price is trading in a range of $254.44 - $266.05.
Welch & Forbes LLC Increased Glaxosmithkline Plc (NYSE:GSK) by $6.90 Million ...
Welch & Forbes Llc increased its stake in Glaxosmithkline Plc (NYSE:GSK) by 34.66% based on its latest 2016Q1 regulatory filing with the SEC.
Today's Top Gainers in the Market GlaxoSmithKline plc (NYSE:GSK) from ...  The Daily Leicester
GlaxoSmithKline plc (NYSE:GSK) Upcoming Earnings: What matter for investors?  The Voice Registrar